The data are largely in line with those seen at 5 years, but the follow-up reassures there’s no concern about valve ...

Reaching participants through retail pharmacies, the study speaks to how much VHD goes underrecognized—with a few surprises.

The device, which is delivered transapically, represents an option for very sick patients who previously have had none.

The everolimus scaffold, which had mostly disappeared by 3 years, was still associated with fewer reinterventions than PTA.

Operators are excited about a device that avoids transapical access, a limitation of other systems, says Gilbert Tang.

The DCB is meant to address long-term stent-related complications and avoid adding yet another metal layer in ISR.

The first of its kind RCT in acute intermediate-high-risk PE used a surrogate endpoint, but more data are on the horizon.

“Cutting balloon angioplasty is a reasonable and less costly option when compared with intravascular lithotripsy for the ...

The real-world Evoque and new TRILUMINATE findings provide an “extension” from the pivotal trials, Dharam Kumbhani says.

Mamas Mamas, Christian Spaulding, and Simon Ecclehsall discuss the one-year results of the SELUTION DeNovo Trial.

The pilot study was small, but it suggested music therapy before and during PCI could lower BP and heart rate after PCI.

Researchers hoped the technique might involve lower exposure compared with right transradial access, but this didn’t pan out.